Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 499 (RNA5SP499) is a non-functional, non-coding region of the human genome formed by duplication or retrotransposition of the canonical 5S ribosomal RNA gene. Unlike 5S rRNA, which is an essential component of the large ribosomal subunit involved in protein synthesis, RNA5SP499 is classified as a pseudogene: a sequence with high similarity to 5S rRNA but disrupted by mutations so that it does not produce functional rRNA or protein. Pseudogenes like RNA5SP499 are not considered drug targets, receptors, or enzymes, and have no known direct therapeutic relevance. While some pseudogenes in general may play regulatory roles in gene expression by acting as RNA decoys or through interaction with RNA-binding proteins, there is no evidence that RNA5SP499 is functionally transcribed or involved in disease processes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 499 (RNA5SP499).